Parallel Advisors, LLC Taro Pharmaceutical Industries LTD Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Parallel Advisors, LLC holds 19 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 19 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$0.0 - $42.97 $0 - $816
19 New
19 $0
Q2 2023

May 20, 2024
SELL
$24.24 - $40.97 $993 - $1,679
-41 Reduced 65.08%
22 $0
Q2 2023

Aug 04, 2023
SELL
$24.24 - $40.97 $993 - $1,679
-41 Reduced 65.08%
22 $0
Q1 2023

May 20, 2024
BUY
$23.0 - $31.59 $1,449 - $1,990
63 New
63 $1,000
Q1 2023

Apr 25, 2023
SELL
$23.0 - $31.59 $3,473 - $4,770
-151 Reduced 70.56%
63 $1,000
Q4 2022

Feb 03, 2023
BUY
$27.6 - $32.99 $2,042 - $2,441
74 Added 52.86%
214 $6,000
Q3 2022

Nov 10, 2022
BUY
$28.74 - $39.9 $4,023 - $5,586
140 New
140 $4,000
Q2 2022

Aug 01, 2022
SELL
$35.0 - $43.59 $6,405 - $7,976
-183 Closed
0 $0
Q1 2022

Apr 28, 2022
SELL
$43.12 - $50.3 $9,702 - $11,317
-225 Reduced 55.15%
183 $8,000
Q4 2021

Jan 20, 2022
BUY
$47.6 - $65.0 $16,517 - $22,555
347 Added 568.85%
408 $20,000
Q3 2021

Nov 02, 2021
BUY
$62.34 - $73.38 $1,433 - $1,687
23 Added 60.53%
61 $4,000
Q4 2020

Feb 02, 2021
BUY
$54.4 - $73.42 $217 - $293
4 Added 11.76%
38 $3,000
Q3 2020

Oct 27, 2020
SELL
$54.41 - $68.2 $1,197 - $1,500
-22 Reduced 39.29%
34 $2,000
Q2 2020

Jul 16, 2020
SELL
$61.66 - $70.16 $4,131 - $4,700
-67 Reduced 54.47%
56 $3,000
Q1 2020

Apr 27, 2020
BUY
$59.35 - $88.73 $5,578 - $8,340
94 Added 324.14%
123 $7,000
Q4 2019

Jan 30, 2020
SELL
$74.18 - $97.92 $8,011 - $10,575
-108 Reduced 78.83%
29 $3,000
Q3 2019

Nov 01, 2019
BUY
$75.36 - $86.57 $10,324 - $11,860
137 New
137 $10,000
Q2 2019

Aug 05, 2019
SELL
$83.92 - $108.88 $335 - $435
-4 Closed
0 $0
Q2 2018

Jul 30, 2018
SELL
$97.62 - $120.59 $2,050 - $2,532
-21 Reduced 84.0%
4 $0
Q1 2018

May 08, 2018
SELL
$95.91 - $107.26 $479 - $536
-5 Reduced 16.67%
25 $2,000
Q4 2017

Feb 13, 2018
SELL
$104.5 - $126.38 $731 - $884
-7 Reduced 18.92%
30 $3,000
Q3 2017

Nov 15, 2017
BUY
$97.26 - $116.2 $3,598 - $4,299
37 New
37 $4,000
Q3 2017

Nov 14, 2017
SELL
$97.26 - $116.2 $4,668 - $5,577
-48 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
48
48 $5,000

Others Institutions Holding TARO

# of Institutions
9
Shares Held
17K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email